Clinical and manufacturing working groups created to develop FDA engagement policies
NEW CANAAN, CT— The Cancer Vaccine Consortium (www.sabin.org/cv_consortium.htm) will hold its third semi-annual meeting April 1-2, 2004 in Orlando, Florida, to explore federal regulation of cancer vacci
FDA workshop to highlight event
NEW CANAAN, CT—The Board of Trustees of the Albert B. Sabin Vaccine Institute announced the election of their newest board member, Walter Orenstein, MD. Recently recruited as Professor of Medicine and Pediatrics at Emory University School of Medicine, Dr. Orenstein’s posts at Emory will include director of the Program for Vaccine Policy and Development and associate director of the Vaccine Center. Dr.
Dr. Walter Orenstein Named to Board of Vaccine Think Tank
Sabin Vaccine Institute Convenes Sixth Annual Meeting at Walker’s Cay
NEW CANAAN, CT— Approximately forty of the world’s leading cancer vaccine researchers will meet this week at a scientific colloquium organized by the Albert B. Sabin Vaccine Institute. Convening in think-tank sessions, they will report on the latest developments in this promising field of therapy focused on stimulation of the body’s immune system to attack existing cancerous cells.
The U.S. Government's commitment to rapidly develop biomedical countermeasures against bioterrorist threats has stimulated a tremendous boost to biodefense research, a big push to expand research resources and facilities, and a growing dedication to build a robust biodefense industry.